首页 | 本学科首页   官方微博 | 高级检索  
检索        

Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study
作者姓名:Li S  Nie Z  Li N  Li J  Zhang P  Yang Z  Mu S  Du Y  Hu J  Yuan S  Qu H  Zhang T  Wang S  Dong E  Qi D
作者单位:[1]DepartmentofGastroenterology,GeneralHospitalofBeijingMilitaryRegion,Beijing100700,China [2]261HospitalofPLA,Beijing100094,China
摘    要:Objective To assess the prevalence of colorectal cancer(CRC)in Beijing and the reliability or the sequential fecal occult blood test(SFOBT)for CRC screening.Methods Of the natural population(48 100 persons)in several Beijing communities,we screened 26 827 persone with age over 30 using the SFOBT screening program,Guaiacum Fecal Occult Blood Test(GFOBT),lmmuno Fecal Occult Blood Test(IFOBT),and colonoscopies.Results The screening rate of the population was 74%.The positive rate of SFOBT was 5.6%.The prevalence of CRC in the entire population of Beijing was therefore calculated to be 36.57/10^5.Of 12 CRC detected patients,4 cases were in stage DukesA (33.33%),7 cases in stage Dukes B(58.33%),only 1 case(8.34%)in stage Dukes C.Conclusions The prevalence of CRC in Beijing is one of the highest in China,Individuals at high risk for CRC or those over 50 years of age should be considered as primary candidates for screening,SFOBT screening is a cost-effective and reliable method for early detection of CRC.

关 键 词:结直肠癌  筛检  北京  自然人群  连续隐性便血试验

Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study
Li S,Nie Z,Li N,Li J,Zhang P,Yang Z,Mu S,Du Y,Hu J,Yuan S,Qu H,Zhang T,Wang S,Dong E,Qi D.Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study[J].Chinese Medical Journal,2003,116(2):200-202.
Authors:Li Shirong  Nie Zhaohua  Li Nan  Li Junxiang  Zhang Ping  Yang Zhaoxu  Mu Shankun  Du Yaping  Hu Jichun  Yuan Shenyuan  Qu Hanting  Zhang Taichang  Wang Shixin  Dong Enyu  Qi Defang
Institution:1. Department of Gastroenterology, General Hospital of Beijing Military Region, Beijing 100700, China
2. No. 261 Hospital of PLA, Beijing 100094, China
3. No. 309 Hospital of PLA, Beijing 100077, China
4. Dongfang Hospital, Beijing 100021, China
5. Tiantan Hospital, Beijing 100050, China
6. General command Hospital, Beijing 100039, China
7. Guangdian Hospital, Beijing 100052, China
8. Tongren Hospital, Beijing 100730, China
9. Fuxing Hospital, Beijing 100054, China
10. Haidian Hospital, Beijing 100080, China
11. Beijing People's Hospital, Beijing Medical University, Beijing 100044, China
12. Xuanwu Hospital, Beijing 100053, China
13. Chaoyang Hospital, Beijing 100020, China
14. China-Japan friendship Hospital, Beijing 100029, China
15. General Railway Hospital, Beijing 100038, China
Abstract:To assess the prevalence of colorectal cancer (CRC) in Beijing and the reliabili ty of the sequential fecal occult blood test (SFOBT) for CRC screening Methods Of the natural population (48?100 persons) in several Beijing communities, we screened 26?827 persons with age over 30 using the SFOBT screening p rogram, Guaiacum Fecal Occult Blood Test (GFOBT), Immuno Fecal Occult Blood Test (IFOBT), and colonoscopies Results The screening rate of the population was 74% The positive rate of SFOBT was 5 6% The prevalence of CRC in the entire population of Beijing was therefore c alculated to be 36 57/10 5 Of 12 CRC detected patients, 4 cases were in stage Dukes A (33 33%), 7 cases in stage Dukes B (58 33%), only 1 case (8 34% ) in stage Dukes C Conclusions The prevalence of CRC in Beijing is one of the highest in China Individuals at high risk for CRC or those over 50 years of age should be considered as primary candidates for screening SFOBT screening is a cost effective and reliable me thod for early detection of CRC
Keywords:colorectal cancer  screening  fecal occult blood test
本文献已被 CNKI 维普 万方数据 PubMed 等数据库收录!
点击此处可从《中华医学杂志(英文版)》浏览原始摘要信息
点击此处可从《中华医学杂志(英文版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号